Circular No. 10/2016/TT-BYT promulgates the List of domestically produced drugs meeting treatment requirements, pricing, and supply capacity. This document stipulates principles and criteria for building the list as well as the responsibilities of the Drug Administration Department in updating the list.
적용 범위
Healthcare facilities, pharmaceutical manufacturing enterprises, organizations related to drug management and use
핵심 사항
- The List of domestically produced drugs meeting treatment requirements, pricing, and supply capacity is promulgated in Appendix I (Article 1).
- Principles for building the list are based on specific criteria set out in Appendix II (Article 2).
- The Drug Administration Department is responsible for proposing updates, additions, or adjustments to the drug list in accordance with actual conditions (Article 3).
- This Circular takes effect from July 1, 2016.
- Agencies, organizations, and individuals encountering difficulties during implementation must promptly report to the Ministry of Health for resolution (Article 4).
🌐 이 문서의 사회적 영향
- Facilitate healthcare facilities in easily selecting domestically produced drugs that meet treatment requirements.
- Create favorable conditions for domestic pharmaceutical manufacturing enterprises to develop.
- Ensure stable drug supply and reasonable pricing.
❓ 자주 묻는 질문
Where is the drug list promulgated?
The drug list is promulgated in Appendix I of this Circular.
On what criteria are the principles for building the list based?
Criteria for building the list are specified in detail in Appendix II.
Who is responsible for updating the drug list?
The Drug Administration Department is responsible for proposing updates, additions, or adjustments to the drug list.
전문
CIRCULAR
ISSUING THE LIST OF DOMESTICALLY PRODUCED MEDICINES MEETING TREATMENT REQUIREMENTS, PRICES, AND SUPPLY CAPACITY
BASED ON THE BID LAW NUMBER 43/2013/QH13OF NOVEMBER 26, 2013;
BASED ON DECREE NUMBER 63/2014/NĐ-CP OF JUNE 26, 2014 OF THE GOVERNMENT REGARDING THE SELECTION OF CONTRACTORS UNDER THE BID LAW;Nghị định số 6 năm 2014 của Chính phủ quy định chi tiết một số điều của Luật đấu thầu về lựa chọn nhà thầu;detailed implementation of certain provisions of the Labor Law regarding unemployment insurance Detailed Rules for Implementation thực hiện một số Article of the Bidding Law regarding the selection of contractors;
Decree No. DECREE NO. 63/2012/NĐ-CP dated August 31, 2012 of the GovernmentHealth inspection,For traditional medicine doctors, traditional medicine practitioners, licensed traditional medicine practitioners, and those with hereditary prescriptions or hereditary treatment methods, the scope of professional activities shall be implemented according to another Circular issued by the Minister of Health.
At the proposal of the Director of the Drug Administration Department;
THE MINISTER OF HEALTH ISSUES THIS CIRCULAR TO ESTABLISH A LIST OF DOMESTICALLY PRODUCED MEDICATIONS MEETING TREATMENT REQUIREMENTS, DRUG PRICES, AND SUPPLY CAPABILITIES.
Article 1. ATTACHED TO THIS CIRCULAR IS A LIST OF DOMESTICALLY PRODUCED MEDICATIONS MEETING TREATMENT REQUIREMENTS, DRUG PRICES, AND SUPPLY CAPABILITIES AS SET OUT IN ANNEX I.
ARTICLE 2. PRINCIPLES AND CRITERIA FOR BUILDING THE LIST
THE LIST OF DOMESTICALLY PRODUCED MEDICATIONS MEETING TREATMENT REQUIREMENTS, DRUG PRICES, AND SUPPLY CAPABILITIES SHALL BE DEVELOPED BASED ON THE CRITERIA AND PRINCIPLES SET OUT IN ANNEX II ATTACHED TO THIS CIRCULAR.
Article 3. Implementation Organization
THE DIRECTOR OF THE DRUG MANAGEMENT CIRCULAR RECOMMENDS UPDATING, ADDING, OR ADJUSTING THE LIST OF MEDICATIONS TO SUIT CURRENT SITUATIONS AND ENSURE TIMELY AVAILABILITY OF DRUGS FOR PREVENTIVE AND CURATIVE HEALTH SERVICES AT HEALTH FACILITIES.
Article 4. Implementation provisions
THIS CIRCULAR SHALL TAKE EFFECT FROM JULY 1, 2016. IF THERE ARE ANY DIFFICULTIES OR OBSTACLES DURING IMPLEMENTATION, THEY SHOULD BE REPORTED PROMPTLY TO THE MINISTRY OF HEALTH (DRUG MANAGEMENT DEPARTMENT) FOR CONSIDERATION AND RESOLUTION.
원본 문서(PDF)
관계도
문서를 클릭하면 열립니다. 빨간 테두리＝효력을 변경하는 관계.